Senvest Management, LLC Concert Pharmaceuticals, Inc. Transaction History

Senvest Management, LLC

  • $2.85 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

May 14, 2018
SELL
$19.24 - $28.03 $1.44 Million - $2.1 Million
-75,042 Closed
0 $0
Q4 2017

Feb 12, 2018
SELL
$13.96 - $29.05 $3.34 Million - $6.96 Million
-239,587 Reduced 76.15%
75,042 $1.94 Million
Q3 2017

Nov 13, 2017
BUY
$13.91 - $15.31 $4.38 Million - $4.82 Million
314,629
314,629 $4.64 Million

Others Institutions Holding CNCE

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About CONCERT PHARMACEUTICALS, INC.

CNCE Quotes by TradingView
  • Ticker CNCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,934,600
  • Description
  • Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...
More about CNCE
Track This Portfolio

Track Senvest Management, LLC Portfolio

Follow Senvest Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Senvest Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Senvest Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email